Introduction
============

The phytohormone ABA recruits many diverse elements for the generation and transmission of endogenous signals ([@pcv146-B73], [@pcv146-B41], [@pcv146-B17], [@pcv146-B18], [@pcv146-B35], [@pcv146-B48], [@pcv146-B59], [@pcv146-B77]). Protein kinases and protein phosphatases are proteins that lead to rearrangements in the network of ABA signal transduction ([@pcv146-B50], [@pcv146-B78], [@pcv146-B40], [@pcv146-B45], [@pcv146-B52], [@pcv146-B59], [@pcv146-B66], [@pcv146-B49], [@pcv146-B62], [@pcv146-B12], [@pcv146-B13]). Both protein kinases and protein phosphatases are obligatory for ABA signal transduction. Sucrose non-fermenting 1 (SNF1)-related protein kinases 2 (SnRK2s), Ca^2+^-dependent protein kinases (CDPKs) and calcineurin B-like calcium sensor (CBL)-interacting protein kinases (CIPKs) are all known for their involvement in ABA signaling and stress tolerance, and are identified as interacting partners with particular protein phosphatases type 2C (PP2Cs) ([@pcv146-B50], [@pcv146-B78], [@pcv146-B66]). Key players of ABA signaling such as abscisic acid insensitive 1 (ABI1), abscisic acid insensitive 2 (ABI2) and Hypersensitive to Abscisic acid 1 (HAB1) have been shown to interact with RCAR/PYR/PYL (RCAR, Regulatory Component of ABA Receptor/PYR1, Pyrabactin Resistance 1/PYL, PYR1-like), putative ABA receptors that regulate SnRK kinases ([@pcv146-B66]). ABI1 and ABI2, along with CIPK20, CIPK8, CIPK14 and CIPK15, manage protein--protein interactions and regulate ABA signaling, gene expression and stress response ([@pcv146-B19], [@pcv146-B50], [@pcv146-B36], [@pcv146-B1]). Other PP2C-interacting partners include transcription factors ([@pcv146-B20]), antioxidant enzymes ([@pcv146-B44]), constituents of the chromatin remodeling complex ([@pcv146-B57]) and components of the ethylene biosynthetic pathway ([@pcv146-B37]), which have likewise been identified as important to the ABA signaling network.

Despite studies indicating that mitogen-activated protein kinase (MAPK) cascades are important for ABA signaling, little is known about the interplay between MAPKs and PP2Cs in this pathway. A MAPK cascade is a conserved module comprised of at least three elements: MKKKs, MKKs and MAPKs. A group of MKKKKs have also been identified ([@pcv146-B25], [@pcv146-B76]). MKKKs link upstream receptors with downstream MKKs. MKKKs (as dual specificity kinases) phosphorylate MKKs on Ser/Thr residues in conserved S/T-X3-5-S/T motifs localized in an activation loop (T-loop). Once activated, the MKKs phosphorylate MAPKs at the TxY motif located in their T-loop. Upon activation, the MAPKs phosphorylate downstream substrates, thereby initiating various cellular responses. Among the MAPKs, MPK6 is known to interact with ABI1 PP2C. Both ABI1 and MPK6 are involved in the regulation of biotic and abiotic stress responses ([@pcv146-B31]). In addition, MPK3, MPK6, MPK9 and MPK12 have been identified as regulators of ABA signaling in guard cells ([@pcv146-B29], [@pcv146-B4], [@pcv146-B24], [@pcv146-B58]). MKK1--MPK6 were found to be transiently activated by ABA treatment, to affect downstream generation of H~2~O~2~ and to regulate guard cell aperture ([@pcv146-B72]). Other kinases, such as MPK9 and MPK12, act upstream of anion channels in guard cell ABA signaling ([@pcv146-B23]). In addition, MKK7 and MKK9 are known to act as regulators during stomatal development ([@pcv146-B29]).

Because MKKKs constitute the largest and most complex group of MAP cascade kinases, only a few MPK modules have been recognized and documented. Reaactive oxygen species (ROS) signaling in plants involves the MEKK1--MKK2--MPK4 phosphorylation pathway ([@pcv146-B7], [@pcv146-B54]). In apple, the cascade MdMKK1--MdMPK1 is activated by ABA ([@pcv146-B70]). In Arabidopsis, an unknown MKKK--MKK4/5--MPK3/6 module, and MEKK1--MKK1/2--MPK4, are two MAPK cascades that govern flg22-dependent gene expression ([@pcv146-B61], [@pcv146-B56], [@pcv146-B47], [@pcv146-B3], [@pcv146-B27]). Another MAPK cascade consists of YODA activating MKK4/5--MKK7/MKK9 and MPK3/6: the YODA module is an important protein complex that regulates stomatal development and affects inflorescence architecture by promoting cell proliferation ([@pcv146-B69], [@pcv146-B29], [@pcv146-B43]). Very recently, a MAPK cascade, MAP3K17/18--MKK3--MPK1/2/7/14, was found to play a role in ABA stress signaling ([@pcv146-B10]) and senescence ([@pcv146-B42]).

In this study, we investigated the role of MKKK18 in ABA signaling and response. We find that MKKK18 is regulated by both ABI1 PP2C and the proteasome pathway.

Results
=======

*MKKK18* expression is induced by ABA
-------------------------------------

Previous studies have shown that *MKKK18* expression is increased in response to wounding ([@pcv146-B64]), pathogen attack ([@pcv146-B11]), ozone, mannitol, NaCl and ABA treatment ([@pcv146-B21], [@pcv146-B30], [@pcv146-B35], [@pcv146-B10]). The responsiveness of the *MKKK18* promoter to ABA, quinabactin (a sulfonamide ABA agonist) and ASn compounds (ABA analogs) was also demonstrated ([@pcv146-B51], [@pcv146-B63]). In addition, *MKKK18* expression was found to be deregulated in *abi1-1* and *abi1td* mutants ([@pcv146-B21], [@pcv146-B35]). The expression of *MKKK18* was diminished in *abi1td* ([@pcv146-B35]), and abolished in ABA-insensitive *abi1-1* ([@pcv146-B21]), quadruple *pyr1pyl1pyl2pyr4* and the *hab1*^G246D^ mutants ([@pcv146-B10]), suggesting that the proper transcription of *MKKK18* requires regular ABA signaling.

To gain a more detailed insight into the *MKKK18* gene expression profile, we analyzed public transcriptome data compiled by Genevestigator and eFP Browser. The results indicated that *MKKK18* exhibits low level expression in a range of plant tissues, with the exception of anthers. A relatively high level of expression was observed in root cells, including the epidermis, endodermis, stele, cortex and lateral root cap. A significant increase in *MKKK18* gene expression was observed in guard cells and mesophyll cells in response to ABA treatment.

To verify the ABA responsiveness of *MKKK18*, we studied promoter activity in the 1,622 bp upstream region of the *MKKK18* gene in transgenic plants carrying promoters fused to the β-glucuronidase (GUS) reporter genes. A de novo search for *cis*-acting elements using the PLACE program revealed that the *MKKK18* promoter contained a number of *cis*-regulatory elements. These elements included ABRE (PyACGTGGC) and DRE elements (TACCGACAT) ([@pcv146-B74]), an ASF1 regulatory sequence ([@pcv146-B28]), POLLENLELAT52 ([@pcv146-B2]), a W-box ([@pcv146-B75]) and a TAAAG element required for guard cell-specific gene expression ([@pcv146-B55]). At 24 h after the ABA treatment, a full-length Pro*MKKK18*:GUS construct delivered strong GUS expression in the flowers, leaves and root tissues ([Fig. 1](#pcv146-F1){ref-type="fig"}). In developing flowers, *MKKK18* promoter activity was observed in sepals, anther filaments, ovaries and meristem tissues ([Fig. 1](#pcv146-F1){ref-type="fig"}C--F). GUS staining was visible in root meristem tissues and in areas of lateral root formation ([Fig. 1](#pcv146-F1){ref-type="fig"}G). Pro*MKKK18*:GUS staining was observed in guard cells and trichomes ([Fig. 1](#pcv146-F1){ref-type="fig"}H, [I](#pcv146-F10){ref-type="fig"}). Our results demonstrate that a 1.6 kb upstream sequence was sufficient for *MKKK18* regulation by ABA. Fig. 1Analysis of the activity of the *MKKK18* promoter in transgenic plants expressing the Pro*MKKK18*:GUS construct. (A) Schematic map of the MKKK18 promoter used for transformation and tissue-specific expression of *MKKK18*. (B) The Pro*MKKK18*:GUS seedlings were germinated and grown on half-strength MS medium. Five-week-old plants were treated with either 0.1% methanol (mock) or 100 µM ABA. One representative of five independent lines is shown. (A) No changes in GUS activity after mock treatment. The scale bar represents 2,000 µm. (B--J) Plant samples 24 h after ABA treatment. GUS activity is visible in rosette leaves (B), flower buds and sepals (C), meristem tissues (D), pistils (E), anther filaments (F), lateral roots (G), trichomes (H), leaf guard cells (I) and hydathodes (J).

Active MKKK18 is localized in the nucleus
-----------------------------------------

To determine MKKK18 protein localization in vivo*,* C-terminal green fluorescent protein (GFP) fusions were generated and transiently expressed under the control of the *35S* promoter in *Arabidopsis thaliana* protoplasts. MKKK18--GFP was predominantly localized in the nucleus, whereas, as expected, an empty vector control did not show background fluorescence in any cellular compartment ([Fig. 2](#pcv146-F2){ref-type="fig"}A). Next, we addressed whether kinase activity affected MKKK18 localization. By multisequence alignment of Arabidopsis MAPKKK, we identified conserved residues important for the activity of MKKK18. Based on this analysis, a kinase-inactive allele (K32M) and a permanently active form of MKKK18 (T161E) were generated. The K32M version of the protein is modified in its ATP-binding loop, while the permanently active, T161E form of MKKK18 is modified in the kinase domain. All versions of MKKK18 were fused to GFP and were again expressed in Arabidopsis protoplasts. Interestingly, the K32M version retained barely detectable kinase activity and was localized outside the nucleus. However, the fluorescent signal of the permanently active T161E version of MKKK18--GFP clearly accumulated in the nucleus of Arabidopsis protoplasts, suggesting a role in mediating the signaling function of MKKK18 in this compartment ([Fig. 2](#pcv146-F2){ref-type="fig"}A). Immunoblot analysis confirmed the presence of full-length fusion proteins in protoplasts ([Fig. 2](#pcv146-F2){ref-type="fig"}B). Fig. 2Subcellular localization of the MKKK18 protein in Arabidopsis protoplasts. Active MKKK18 is localized in the nucleus. (A) Microscopy images show nuclear localization of the MKKK18--GFP fusions in Arabidopsis protoplasts. Hoechst H33342 was used as nuclear localization marker. Scale bars are calibrated to 20 µm. (B) MKKK18 protein expression and activity were analyzed by immunoprecipitation using protein-specific anti-MKKK18 antibodies and immunocomplex kinase assay with MBP as a substrate. The immunocomplex assay confirmed residual kinase activity of the *MKKK18K32M-GFP* allele. Western blot detection using anti-GFP antibodies corroborates the presence of MKKK18--GFP fusion proteins. Coomassie Brilliant Blue (CBB) staining confirmed equal loading.

*MKKK18-*overexpressing lines show ABA-related phenotypes at the level of germination and root growth
-----------------------------------------------------------------------------------------------------

To investigate the functions of MKKK18, six independent *MKKK18*-overexpressor lines (Col-0*/35S:MKKK18-GFP*; *MKKK18oe1--MKKK18oe6*) were generated and two T-DNA insertion lines of *MKKK18* in the Columbia (Col-0) background were selected from the SALK and GABI-Kat collections. These knockout lines were designated *mkkk18-1* (SALK_087047) and *mkkk18-2* (GK-244G02). Homozygous *mkkk18-1* and *mkkk18-2* plants were identified by PCR-based genotyping, and the insertion site was confirmed by PCR using T-DNA-specific and gene-specific primers ([Fig. 3](#pcv146-F3){ref-type="fig"}A, [B](#pcv146-F10){ref-type="fig"}). A quantitative real-time PCR (qPCR) analysis confirmed that expression of MKKK18 was abolished in both *mkkk18-1* and *mkkk18-2* ([Fig. 3](#pcv146-F3){ref-type="fig"}C). Fig. 3Germination and root growth assays. (A and B) T-DNA insertion sites derived from the sequencing of genomic DNA isolated from *mkkk18-1* and *mkkk18-2* mutant lines. Black boxes represent an open reading frame. Homozygous knockout mutants were verified by PCR-based genotyping using the following primers: MKKK18LP plus MKKK18RP plus LBb1 for *mkkk18-1* analysis (product size for the WT, ∼960 bp; product for homozygous lines, 750 bp); MEK18F plus GKatTDNA (product for homozygous lines, 850 bp) and GwMK18F plus GwMK18R (product for the WT, 1,001 bp) for *mkkk18-2* genotyping. Primer sequences are indicated in [Supplementary Table S1](http://pcp.oxfordjournals.org/lookup/suppl/doi:10.1093/pcp/pcv146/-/DC1). (C) qPCR analysis confirmed a lack of *MKKK18* expression in homozygous lines. Each quantification was repeated twice with similar results. The results are given as log~2~ of the relative *MKKK18/18S* rDNA expression ratio ± SE (*n* = 6). (D) RD29B and *RAB18* transcript levels in MKKK18 mutants. RD29B and *RAB18* expression levels were determined using three biological replicates and were normalized against 18S rDNA. Each quantification was repeated twice on separate plates. The results are displayed as mean log~2~ fold change ± SE (*n* = 9) of three independent experiments with consistent results. (E and F) Germination and root growth assays. ABA-mediated inhibition of germination (E) and primary root growth (F) in WT Col-0, *MKKK18oe* and *MKKK18* knockout lines. Both *MKKK18oe* \#1 and \#2 lines showed similar results. Values are mean ± SE for three independent experiments (*n* = 30). \**P* \< 0.01; \*\**P* \< 0.001; \*\*\**P* \< 0.0001 with respect to the control WT Col-0 line.

Previous reports showed that MKKK18 is an ABA-activated kinase ([@pcv146-B10], [@pcv146-B42]). To monitor the activation of ABA signaling in the leaves of the knockouts and *MKKK18-oe* lines at the molecular level, the expression of the ABA-induced genes *RD29B* and *RAB18* was examined by qPCR ([Fig. 3](#pcv146-F3){ref-type="fig"}D). In response to treatment with ABA, *RD29B* and *RAB18* expression was significantly down-regulated in both *MKKK18* knockout lines compared with *MKKK18oe* and wild-type (WT) plants (*P* \< 0.001), suggesting that ABA-mediated induction of these genes is regulated by MKKK18.

In the search for ABA-related phenotypes in the *MKKK18* mutants, we first analyzed whether seed germination and root growth were affected by ABA. Seeds of *MKKK18oe* lines and *mkkk18* knockouts were sown on Murashige and Skoog (MS) medium supplemented with ABA, and the germination rate was analyzed and compared with that of WT seeds. As indicated in [Fig. 3](#pcv146-F3){ref-type="fig"}E, both knockout lines showed similar growth rates to WT Col-0 in the presence of low concentrations of ABA. In contrast, Col-0*/35S:MKKK18-GFP* germinated better than the WT Col-0 control, which was supported by the *t*-test results (*P* \< 0.001) between the WT and independent *MKKK18oe* lines. This observation indicated that the *35S:MKKK18-GFP*-overexpressing line displayed insensitivity towards ABA at the level of germination, suggesting that MKKK18 was required for germination. Next, in the search for ABA-related phenotypes, we analyzed ABA-mediated inhibition of root expansion. In the presence of 2 µM ABA, root elongation in seedlings expressing *35S:MKKK18-GFP* was reduced by 15% compared with the WT Col-0 control seedlings (*n* = 46; *P* \< 0.0001). At the same ABA level, the *mkkk18-1* and *mkkk18-2* knockout lines showed improved root growth (40% and 20%, respectively) compared with the WT Col-0 line ([Fig. 3](#pcv146-F3){ref-type="fig"}F).

*MKKK18* affects stomatal development and function
--------------------------------------------------

MAPKs are important elements of signaling cascades that affect stomatal development ([@pcv146-B69], [@pcv146-B29], [@pcv146-B65]). Therefore, we compared the number and density of stomata in 6- and 10-day-old seedlings of both *MKKK18-oe* lines and *MKKK18* knockout lines ([Fig. 4](#pcv146-F4){ref-type="fig"}A). In the cotyledons, the stomatal index (SI) was significantly reduced, by 19% and 26%, in *mkkk18-1* (*P* \< 0.001) and *mkkk18-2* (*P* \< 0.0001), respectively. Consistent with this trend in SI, the abaxial SI for *MKKK18oe* lines was 7% higher than that for WT lines. Because GUS expression driven by the *MKKK18* promoter was detected in guard cells, we analyzed whether MKKK18 was involved in the regulation of stomatal aperture. Compared with leaves from the WT, leaves from both knockout lines showed increased stomatal aperture under normal growth conditions. However, this effect was more pronounced in the *mkkk18-2* mutant ([Fig. 4](#pcv146-F4){ref-type="fig"}B). Measurements of stomatal aperture in response to ABA revealed that stomata from the knockout lines were again significantly more open than in the WT. Accordingly, *MKKK18oe* lines were hypersensitive to ABA-induced stomatal closure ([Fig. 4](#pcv146-F4){ref-type="fig"}C). Next, we analyzed whether MKKK18 acted downstream of responses to CaCl~2~ or H~2~O~2~ in guard cell ABA signaling. Compared with WT Col-0, the knockout lines were significantly, if only slightly, impaired in H~2~O~2~-induced stomatal closure but not in response to CaCl~2~ ([Fig. 4](#pcv146-F4){ref-type="fig"}C)~.~ Fig. 4Stomatal development and movement in *MKKK18* knockouts and the *MKKK18*-overexpressing line. (A) Stomatal development is enhanced in the *MKKK18*-overexpressing lines. Representative line drawings show the abaxial surface of cotyledons at day 10. Change in stomatal index and the number of guard cells (GCs) and pavement cells (PCs) per cotyledon in WT Col-0, *MKKK18oe* and MKKK18 knockouts. Data represent the mean ± SD (*n* = 300) of three independent experiments. Scale bar = 50 µm. (B) Increased stomatal aperture of *mkkk18-1* and *mkkk18-2* knockouts compared with the WT in standard conditions (three independent experiments, 60--80 stomatal apertures at each data point). (C) The *mkkk18-1* and *mkkk18-2* knockouts are insensitive to ABA- and H~2~O~2~-induced stomatal closure (two independent experiments, 80 stomatal apertures at each data point). *MKKK18oe* lines were hypersensitive to ABA-, CaCl~2~- and H~2~O~2~-induced stomatal closure (two independent experiments, 100 stomatal apertures at each data point).

MKKK18 is activated by ABA in tobacco
-------------------------------------

To test the mechanism of MKKK18 activation in response to ABA, we generated a peptide-specific antibody against MKKK18. Using alignment tools, we found a unique N-terminal sequence of MKKK18 with no obvious similarity to any other Arabidopsis protein, including MAPKs of any type. To test the specificity of the generated antibodies, we performed immunoprecipitation of recombinant MKKK18--glutathione *S*-transferase (GST) with and without an epitope-mimicking peptide. We found that the generated antibody recognized recombinant MKKK18--GST ([Fig. 5](#pcv146-F5){ref-type="fig"}A, [B](#pcv146-F10){ref-type="fig"}), while pre-incubation of anti-MKKK18-coupled beads with the peptide blocked immunoprecipitation of MKKK18 ([Fig. 5](#pcv146-F5){ref-type="fig"}A). We then tested the antibody in Arabidopsis extracts, but were unable to detect the MKKK18 protein directly, either by immunoblot analysis of the total protein extract or in the immunoprecipitates from WT Col-0 and knockout lines. Nevertheless, MKKK18 immunocomplex activity was detectable in ABA-treated WT Col-0, although not in ABA-treated knockout lines ([Fig. 5](#pcv146-F5){ref-type="fig"}C), demonstrating that both knockout lines are deficient in MKKK18 activity. Overall, these results clearly demonstrate the specificity of the antibody for MKKK18. Fig. 5ABA induces rapid MKKK18 activation in tobacco. (A--C) Generation of MKKK18-specific antibodies. (A) MKKK18 peptide competition assay. Recombinant GST--MKKK18 protein was incubated with anti-MKKK18 with and without 45 µg of blocking peptide. A single band of approximatley 65 kDa specific to GST--MKKK18 is absent in the immunoprecipitates containing the blocking peptide. Immunodetection was performed using anti-MKKK18 antibody. (B) MKKK18--GFP protein immunoprecipitated from tobacco total protein extracts using increasing amounts of anti-MKKK18 and anti-GFP antibodies. The MKKK18--GFP protein was precipitated by 3 µl (lane 1) or 10 µl (lane 2) of MKKK18 antiserum and 0.6 µg (lane 3) or 1.2 µg (lane 4) of anti-GFP antibody, respectively. Immunoblotting with anti-MKKK18 antibodies confirmed the presence of MKKK18--GFP fusion protein. Arrows/Ab indicate anti-MKKK18 antibodies (visible as a band in lane 2) where excess anti-MKKK18 antibody was used in the immunoprecipitation reaction. The 65 kDa band represents MKKK18--GFP protein. (C) Analysis of MKKK18 activity in the *mkkk18* knockout lines. MKKK18 protein was immunoprecipitated from 600 µg of total protein extract isolated from ABA-treated WT Col-0, *mkkk18-1*, *mkkk18-2* and *MKKK18oe* using specific anti-MKKK18 antibodies. Immunocomplex activity was determined using MBP (2 µg) as a substrate. Coomassie Brilliant Blue (CBB) staining of MBP confirmed equal loading. (D) Tobacco plants infiltrated with *Agrobacterium* strain C58C1 harboring *35S:MKKK18-GFP* and *35S:p19* constructs for transient expression. Four to five days after infiltration, the tobacco plants were treated with ABA and tissue samples were collected at the indicated time points. MKKK18 activity was assessed by the immunocomplex assay using anti-MKKK18 antibody and MBP as a substrate. MKKK18--GFP was detected with anti-GFP antibody. CBB staining of MBP confirmed equal loading. The above experiments were repeated several times with similar results.

To analyze the time course of MKKK18 activation in response to ABA, we again performed the kinase immunocomplex assay using myelin basic protein (MBP) as a substrate. *Nicotiana benthamiana* plants were generated that transiently expressed the *35S:MKKK18-GFP* construct, and the MKKK18--GFP protein was immunoprecipitated using the MKKK18-specific antibody ([Fig. 5](#pcv146-F5){ref-type="fig"}D). As expected, treatment with 1 µM ABA caused an increase in the activity of MKKK18, which was observed within 60 min of treatment. Importantly, before ABA treatment we did not observe MKKK18--GFP kinase activity on MBP. Overall, our results demonstrate that MKKK18 activity is indeed regulated by ABA.

ABI1 PP2C interacts with MKKK18 and affects its activation by ABA
-----------------------------------------------------------------

Our previous results showed that MKKK18 expression was significantly affected in the *abi1td* mutant ([@pcv146-B35]). Because MKKK18 is also ABA responsive, and ABI1 is known to be a negative regulator of ABA signaling, we then asked whether ABI1 would affect MKKK18 function. We transformed *abi1td* protoplasts with WT and mutated forms of MKKK18 fused to GFP, and examined their subcellular localization. We observed that the distribution of the various forms of MKKK18--GFP in *abi1td* mesophyll protoplasts was similar to that in WT protoplasts, suggesting that ABI1 did not affect MKKK18 localization ([Supplementary Fig. S1](http://pcp.oxfordjournals.org/lookup/suppl/doi:10.1093/pcp/pcv146/-/DC1)).

We next tested whether ABI1 would interact with MKKK18 using yeast two-hybrid, GST pull-down and bimolecular fluorescence complementation (BiFC) assays. Full-length ABI1 (and homologous ABI2 PP2C as a control) and MKKK18 cDNA were fused to either the binding domain (BD) or the activation domain (AD) for yeast two-hybrid analysis and double-transformed yeast lines were generated. Positive results, indicating interaction, were seen only for the ABI1--MKKK18 pair ([Fig. 6](#pcv146-F6){ref-type="fig"}A, [B](#pcv146-F10){ref-type="fig"}; [Supplementary Fig. S2](http://pcp.oxfordjournals.org/lookup/suppl/doi:10.1093/pcp/pcv146/-/DC1)). The binding of ABI1 to MKKK18 was then analyzed using pull-down assays. Streptag-ABI1, and Streptag-ABI2 as a control, were purified from plant extracts and incubated with recombinant MKKK18--GST and His-MKKK18, respectively. Again, only ABI1 was capable of binding MKKK18, indicating substrate specificity of ABI1 PP2Cs for interaction with MKKK18 ([Fig. 6](#pcv146-F6){ref-type="fig"}C, [D](#pcv146-F10){ref-type="fig"}). This result was further confirmed by BiFC experiments using ABI1 (or ABI2 as a control) with MKKK18, which also revealed that ABI1 and MKKK18 were capable of interacting ([Fig. 6](#pcv146-F6){ref-type="fig"}E, [F](#pcv146-F10){ref-type="fig"}; [Supplementary Fig. S3](http://pcp.oxfordjournals.org/lookup/suppl/doi:10.1093/pcp/pcv146/-/DC1)). Fig. 6MKKK18 interacts with the ABI1 protein phosphatase. (A) Yeast two-hybrid analysis of the interaction between MKKK18 and ABI1/2 PP2Cs. Diploid yeast colonies were grown on double (DDO-SD medium without Leu and Trp) or quadruple selective medium (QDO-SD medium without Leu, Trp, His or Ade) with or without supplemented X-α-Gal and aureobasidin. The bait (MKKK18) did not autoactivate the reporter genes in yeast. (B) Detection of ABI1/2 and MKKK18 expression in diploid yeast strains. Expression of BD and AD fusion proteins in yeast was determined by immunoblotting using specific anti-ABI1, anti-ABI2 and anti-MKKK18 antibodies. (C and D) Pull-down assays to verify the interaction of ABI1/2 with MKKK18. Input lines represent 100% of the ABI1/2. Recombinant GST--MKKK18 or His-MKKK18 was pre-coupled to glutathione--Sepharose, and incubated with StrepTag-ABI1 or StrepTag-ABI2, respectively. Pulled-down StrepTagged ABI1 protein was detected (IB) with the epitope tag antibody. The presence of recombinant protein was confirmed using anti-MKKK18 antibody. (E and F) ABI1--MKKK18 interaction occurs within the nucleus. BiFC analysis in Arabidopsis protoplasts expressing full-length ABI1/2 and MKKK18 fused to cECFP or nVenus, respectively. RFP (E) was used as a transformation control. CFP--CBP20 (cyan fluorescent protein--Cap Binding Protein 20) (F) was used as a marker of nuclear localization.

Consequently, we analyzed the effect of ABI1 PP2C activity on MKKK18 activation. Arabidopsis mesophyll protoplasts were transfected with *35S:MKKK18--GFP* constructs, and immunocomplex MKKK18 activity was determined by in vitro kinase assays in the presence of recombinant ABI1 or ABI2 proteins ([Fig. 7](#pcv146-F7){ref-type="fig"}A, [B](#pcv146-F10){ref-type="fig"}). ABI1 but not ABI2 inhibited MKKK18 kinase activity. As a control treatment, the activities of both PP2Cs were assessed using a non-radioactive phosphatase assay ([Fig. 7](#pcv146-F7){ref-type="fig"}A). Previous studies revealed that ABI1 can inhibit the autoactivation of SnRK2 kinases ([@pcv146-B46]). To test the mechanism of MKKK18 activation and the role of ABI1 in this process, we purified recombinant GST--MKKK18 and analyzed the kinase activity in vitro in the presence of the downstream in vivo substrate, MKK3 ([@pcv146-B10], [@pcv146-B42]), and an artificial substrate, MBP. As a positive control for the kinase activity assay, SnRK2.6 was used ([Fig. 7](#pcv146-F7){ref-type="fig"}C). Interestingly, we observed no autophosphorylation activity of MKKK18 and as a consequence no phosphorylation of the substrates. These results indicate that MKKK18 activity is precisely controlled and that ABI1 does not regulate autoactivation of MKKK18. Fig. 7ABI1 inhibits MKKK18 activity. (A) Phosphatase activity of recombinant ABI1 and ABI2 proteins. The enzyme reactions were performed in a 50 µl final volume containing 3--5 µg pf GST--ABI1 or GST--ABI2. The results presented are the means from three independent biological replicates. (B) ABI1 inactivates MKKK18. The MKKK18--GFP immunocomplex was incubated with 3 µg of GST--ABI1 and GST--ABI2 (as a negative control), after which the kinase activity was determined with MBP as a substrate. Equal loading was confirmed by Coomassie Brilliant Blue (CBB) staining of MBP. The ^32^P-labeled MBP bands were quantified and then normalized against the intensity of the corresponding control band using ImageJ software. Data are means ± SD of the relative band intensities from three independent experiments. An asterisk (\*) indicates statistically significant changes determined using Student's *t*-test. (C) Recombinant MKKK18 has no autophosphorylation activity in vitro*.* GST--MKKK18 was incubated with MBP or/and MKK3, without or in the presence of \[^32^P\]ATP. Bands of GST--MKKK18, MKK3--GST and GST--SnRK2.6 are indicated by a filled circle, a triangle and an arrow, respectively. Protein loading was confirmed by CBB staining. The blots shown are representative of three independent trials.

Finally, to confirm the role of ABI1 in the regulation of MKKK18 activity, we examined MKKK18 activation in WT Col-0 and *abi1td* after ABA treatment. Previously, it was reported that MKKK18 expression is absent in the ABA receptor quadruple *pyr1pyl1pyl2pyl4* mutant ([@pcv146-B10]). Therefore, SnRK2.6 kinase, another crucial element of the ABA pathway, was also included in this analysis. Under the conditions indicated, we observed a stronger induction of MKKK18 activity in the *abi1td* mutant than in the WT Col-0 plants after 90 min of ABA treatment ([Fig. 8](#pcv146-F8){ref-type="fig"}A, [B](#pcv146-F10){ref-type="fig"}). Under the same conditions, ABA-induced MKKK18 activation was abolished in the *snrk2.6* mutant. These experiments demonstrated that both ABI1 PP2C and SnRK2.6 affect functional activation of MKKK18 in response to ABA treatment. Fig. 8MKKK18 activity increases in the *abi1td* mutant in response to ABA treatment. (A) Seedlings of WT Col-0 and the *abi1td* and *snrk2.6* mutants were treated with 100 µM ABA for the indicated times. A 600 µg aliquot of total protein was used for the immune complex MKKK18 activity assay using anti-MKKK18 antibody. Coomassie Brilliant Blue (CBB) staining of MBP confirmed equal loading. Due to low abundance, the endogenous MKKK18 protein was not detectable by immunoblot analysis. The results shown are representative of three independent experiments (*n* = 9) with consistent results. (B) ^32^P-labeled MBP bands were quantified using ImageJ software and normalized by taking the radioactivity of the band in the absence of ABA as 1. Data are means ± SD of the relative band intensities from three independent experiments (*n* = 9).

MKKK18 accumulation is regulated by ABI1 and the ubiquitin--proteasome pathway
------------------------------------------------------------------------------

The MKKK18 protein was found to be in low abundance and, indeed, undetectable in total protein extracts from WT Col-0 plants. This feature of MKKK18 resembles other short-lived proteins, such as aminocyclopropane-1-carboxylic acid synthases (ACC synthases) 2 and 6, whose degradation is mediated by the ubiquitin--proteasome pathway ([@pcv146-B34], [@pcv146-B26]). Recently, we demonstrated that ABI1 controls turnover of ACC synthase 6 ([@pcv146-B37], [@pcv146-B38]); therefore, we hypothesize that ABI1 might also be involved in the regulation of MKKK18 stability. To test this hypothesis, we first examined MKKK18 transcript levels in WT plants and two independent *ABI1* knockout lines, *abi1td* ([@pcv146-B35]) and *abi1-2* (Saez et al. 2006). Importantly, in response to 90 min of 50 µM ABA treatment, *MKKK18* expression was significantly lower in both *ABI1* knockout lines compared with WT plants (*P* \< 0.0001) ([Fig. 9](#pcv146-F9){ref-type="fig"}A). Because the decrease in MKKK18 transcript accumulation does not explain the increased MKKK18 kinase activity in the ABI1 knockout, we examined the turnover of MKKK18. Cell-free degradation assays showed that recombinant GST--MKKK18 was degraded more slowly in *abi1td* than in WT cell extracts ([Fig. 9](#pcv146-F9){ref-type="fig"}B). The degradation was blocked by MG132 (a proteasome inhibitor) in both *abi1td* and WT plant extracts. The half-life of GST--MKKK18 in the assay was substantially longer in *abi1td* protein extracts compared with WT protein extracts ([Fig. 9](#pcv146-F9){ref-type="fig"}C, [D](#pcv146-F10){ref-type="fig"}). Overall, these results demonstrate that ABI1 PP2C regulates MKKK18 turnover. Fig. 9Proteasome-dependent degradation of MKKK18 is ABA-dependent and regulated by ABI1. (A) qPCR analysis of MKKK18 transcript accumulation in response to treatment with 50 µM ABA for 90 min in WT Col-0, *MKKK18oe*, *abi1td* and *abi1-2* strains. *MKKK18* expression levels were determined using three biological replicates and were normalized against 18S rDNA. The results are displayed as mean log~2~ fold change ± SE (*n* = 9) of three independent experiments with consistent results. (B) MKKK18 stability in the cell-free degradation assay. GST--MKKK18 was incubated with 100 µg of protein extract from either WT Col-0 or *abi1td* protoplasts incubated with or without 100 µM MG132 for 6 h in the dark. GST--MKKK18 protein levels at the indicated time points were determined by immunoblotting using anti-GST antibodies. Ponceau S staining confirmed equal loading. (C and D) Half-life plot for cell-free degradation of MKKK18 in WT Col-0 (C) and *abi1td* (D) extracts. Immunoblot images from each experiment were recorded simultaneously using a G:BOX Chemi XR5 fluorescence and chemiluminescence imaging system (Syngene), and the results were quantified using ImageJ software. (E) CHX treatment suppresses accumulation of MKKK18. Arabidopsis protoplasts expressing *35S:MKKK18-GFP* were treated with 3 mM CHX, 3 mM CHX and 100 µM MG132, or given a mock treatment. The blot is representative of four experiments. MKKK18--GFP protein levels were determined by immunoblotting using anti-GFP antibodies. Ponceau S staining confirmed equal loading. MKKK18 protein bands were quantified using ImageJ software and normalized to the control (mock) band (set as 1). (F) MKKK18 protein levels are modified by ABA. GST--MKKK18 was incubated with 100 µg of total protein extract isolated from WT Col-0 incubated with or without 50 µM ABA for 3 h in the dark. GST--MKKK18 protein levels at the indicated time points were determined by immunoblotting using GST antibodies. Ponceau S staining confirmed equal loading. MKKK18 protein bands were quantified using ImageJ software and normalized to the control band (set as 1).

Next, we investigated MKKK18--GFP abundance in Arabidopsis protoplasts transiently expressing *35S:MKKK18-GFP*. Under such conditions, the degradation rate of MKKK18 could be affected by its increased synthesis; therefore, to distinguish between translational or post-translational effects, we used a protein synthesis inhibitor, cycloheximide (CHX) ([Fig. 9](#pcv146-F9){ref-type="fig"}E). As expected, CHX treatment significantly reduced the accumulation of MKKK18 protein. Notably, simultaneous CHX and MG132 treatment prevents a reduction in MKKK18 protein levels, demonstrating that MKKK18 is degraded by the proteasome pathway.

Because both MKKK18 transcript level and kinase activity are regulated by ABA, we asked whether ABA affects the MKKK18 protein level. Again, the cell-free degradation assay was performed to test whether MKKK18 stability is affected by ABA. GST--MKKK18 recombinant protein was incubated with protein extracts prepared from WT protoplasts treated with 50 µM ABA or mock treated. GST--MKKK18 was rapidly degraded when incubated with WT protein extracts and this degradation was blocked by ABA ([Fig. 9](#pcv146-F9){ref-type="fig"}F). These results indicate that ABA regulates MKKK18 protein stability.

Discussion
==========

Previously it was shown that ABA activates several MAPKs to perform various functions in the cell ([@pcv146-B9], [@pcv146-B10]). In this study, we demonstrate that MKKK18 is also an element of the ABA response pathway and that it is specifically expressed in guard cells ([Fig. 1](#pcv146-F1){ref-type="fig"}I) and root meristem tissues ([Fig. 1](#pcv146-F1){ref-type="fig"}G). Interestingly, active MKKK18 is targeted specifically to the nucleus. We also show that MKKK18 kinase activity is increased by ABA treatment. Consistent with this, we show that MKKK18 is involved in ABA-related responses including stomatal development ([Fig. 4](#pcv146-F4){ref-type="fig"}), stomatal movement ([Fig. 4](#pcv146-F4){ref-type="fig"}), ABA inhibition of germination and root growth ([Fig. 3](#pcv146-F3){ref-type="fig"}). Notably, we identify ABI1 PP2C as an MKKK18-interacting protein ([Fig. 6](#pcv146-F6){ref-type="fig"}) and we demonstrate that ABI1 inhibits MKKK18 activity ([Fig. 7](#pcv146-F7){ref-type="fig"}B). We also establish that MKKK18 is unstable and is degraded by the 26S proteasome, providing evidence that ABI1 promotes proteasomal degradation of MKKK18 ([Fig. 9](#pcv146-F9){ref-type="fig"}).

ABA plays a major role in various aspects of plant growth and development, and is pivotal in stomatal function ([@pcv146-B5], [@pcv146-B9], [@pcv146-B60]). In this study, we show that loss of MKKK18 function leads to impaired stomatal development and a constitutive phenotype with more open stomata. As previously documented, ABA inhibits initiation of stomatal development ([@pcv146-B65]), reducing the number of stomata per leaf and decreasing the SI ([@pcv146-B16], [@pcv146-B65]). Our results show that the SI of the *MKKK18oe* lines is significantly higher than in the WT Col-0 line ([Fig. 4](#pcv146-F4){ref-type="fig"}). Accordingly, the SIs of both *MKKK18* knockouts are significantly lower ([Fig. 4](#pcv146-F4){ref-type="fig"}), suggesting that MKKK18 acts as a positive regulator of stomatal development. Interestingly, another MKKK, YODA, which fine-tunes this process, acts as a negative regulator in the early stages, but acts as a positive regulator in the final step, of stomatal development ([@pcv146-B69], [@pcv146-B29]). According to [@pcv146-B10] and [@pcv146-B42], the MKKK17/18 kinase cascade recruits MKK3--MPK1/2/7/14. YODA activates the MKK4/5--MKK7/MKK9 and MPK3/6 pathways during stomatal development. Thus we may hypothesize that the MKKK18 pathway is largely independent of YODA, although it may co-operate in the final stages of stomatal development. The involvement of different MAPK cascades in the same process was reviewed recently ([@pcv146-B9]), while participation of the same cascades in different processes has also been reported ([@pcv146-B69], [@pcv146-B43]).

As is clear from the phenotypes described in this study, *MKKK18oe* lines show different responses to ABA stimulus depending on developmental stage and cell type. For example, germinating *MKKK18oe* seedlings exhibit a weak ABA-insensitive phenotype ([Fig. 3](#pcv146-F3){ref-type="fig"}E), while overexpression of *MKKK18* also causes ABA-hypersensitive stomatal closing and root growth ([Figs. 3](#pcv146-F3){ref-type="fig"}C, [4F](#pcv146-F4){ref-type="fig"}). This suggests that similar MKKK18-based signaling pathways may operate in these processes, but the opposite phenotypic responses to ABA stimulus may also be observed, indicating that MKKK18 signaling integrates various pathways.

Protein kinase autoactivation, via phosphorylation of the activation loop, is a common regulatory mechanism that switches the status of the signaling cascades to standby. Very recently, it was shown that recombinant GST--MKKK18 is able to autophosphorylate in vitro ([@pcv146-B42]). Our data appear to contradict this result. Compared with a positive control, SnRK2.6 kinase ([@pcv146-B46]), we conclude that MKKK18 does not undergo autoactivation ([Fig. 7](#pcv146-F7){ref-type="fig"}). In our hands, GST--MKKK18 autophosphorylates neither during production in bacterial cells nor in in vitro kinase assays ([Fig. 7](#pcv146-F7){ref-type="fig"}C). Our results suggest, therefore, that *MKKK18* must be activated by an upstream kinase (possibly a receptor kinase or another type of protein kinase) in response to ABA. Future studies are necessary to determine specific sites of regulatory significance in MKKK18.

To determine the exact mechanism underlying MKKK18 regulation, we tested the interaction between MKKK18 and the homologous phosphatases ABI1 and ABI2 ([Fig. 6](#pcv146-F6){ref-type="fig"}). ABI1/2 are known to be negative regulators of ABA signaling that interact with the ABA receptors RCAR/PYR/PYL and SnRK2s ([@pcv146-B40], [@pcv146-B52], [@pcv146-B66], [@pcv146-B67]). Importantly, ABA-induced MKKK18 kinase activity is significantly increased in the ABI1 knockout ([Fig. 8](#pcv146-F8){ref-type="fig"}), while MKKK18 transcript levels were significantly reduced ([Fig. 9](#pcv146-F9){ref-type="fig"}A) compared with the WT. Our results suggest that the ABI1 protein phosphatase is needed for down-regulation of the pathway mediated by MKKK18. Interaction between MKKK18 and ABI1 supports the notion that the MKKK18 cascade operates downstream of the core ABA signaling pathway.

In addition, functional activation of the MKKK18 pathway is also constrained at the transcriptional level. MKKK18 expression is nearly abolished in ABA-insensitive *abi1-1* ([@pcv146-B21]), *hab1*^G246D^ and quadruple *pyr1pyl1pyl2pyr4* ABA receptor mutants ([@pcv146-B10]). Importantly, the *hab1*^G246D^ mutant confers an equivalent hypermorphic mutation to *abi1-1* (*abi1G180D*). Consistent with this, we observed that MKKK18 activity is abolished in the *snrk2.6* mutant and another ABA-insensitive mutant ([Fig. 8](#pcv146-F8){ref-type="fig"}). Because SnRK2.6 activity is abolished or nearly abolished in *snrk2.6*, *abi1-1* and *pyr1pyl1pyl2pyr4* mutants, it is most likely that MKKK18 transcription is controlled by SnRK2.6. In the *abi1td* mutant, decreased MKKK18 transcription compensates for its increased stability. Overall, we may conclude that components of the core ABA pathway regulate MKKK18 function at multiple levels.

Another element of kinase activity regulation, especially in signal transduction pathways, is protein degradation via the proteasome pathway ([@pcv146-B8], [@pcv146-B71], [@pcv146-B53], [@pcv146-B15], [@pcv146-B39]). Ubiquitinated proteins are present at low abundance and are unstable: in mammalian cells, MEKK1 and several isoforms of extracellular signal-regulated kinases (ERKs) are degraded via the proteasome pathway, leading to inactivation of ERK1/2 and c-Jun N-terminal kinase (JNK) pathways mediated by MEKK1 ([@pcv146-B71]). In Arabidopsis, well-documented examples of protein kinase degradation include SnRK1.1, SnRK1.2, GSK3-like kinase and CIPK26 ([@pcv146-B53], [@pcv146-B15], [@pcv146-B39]). Here we demonstrate that the interaction between ABI1 and MKKK18 is necessary for the destruction of the MKKK18 kinase ([Fig. 9](#pcv146-F9){ref-type="fig"}B--D). As shown recently, ABI1 promotes the degradation of ACS6 protein ([@pcv146-B37]). This new role of ABI1 phosphatase is not restricted to a single protein, but also extends to the regulation of MKKK18 activity. We show that ABI1 inhibits MKKK18 activity ([Fig. 7](#pcv146-F7){ref-type="fig"}B) and, using a cell-free assay, we reveal that ABI1 promotes its degradation ([Fig. 9](#pcv146-F9){ref-type="fig"}B--D). Consistent with this, we also show that ABA treatment increases MKKK18 stability in cell-free assays ([Fig. 9](#pcv146-F9){ref-type="fig"}F), presumably due to inhibition of the ABI1 PP2C by ABA. However, it is possible that other mechanisms also regulate MKKK18 turnover. For example, the accumulation of the ABA-responsive transcription factor abscisic acid insensitive5 (ABI5) is achieved by ABA-dependent regulation of KEG E3 ligase turnover ([@pcv146-B33]). In conclusion, our results suggest that ABI1 PP2C can be considered a key player in the ABA-dependent feedback mechanism for resetting various signaling pathways to pre-stimulatory status.

In summary, an important aspect of the current research is the identification of key regulators of the ABA response and their signaling networks. Our current findings demonstrate that phosphorylation and dephosphorylation events play an important role in the transmission of the ABA signal. Although the SnRK2 protein kinases and group A PP2C-type phosphatases constitute a core ABA signaling pathway, the involvement of other groups of proteins, including MAP cascade kinases, has been recognized and documented in earlier studies (for the most recent review, see [@pcv146-B9]). The critical outstanding questions facing researchers are: which MAPKs are involved in ABA signal transduction, and what are the molecular details of the response to this signal? The analyses presented here demonstrate that MKKK18 is an ABA-activated kinase regulated by ABI1 and the proteasome. Based on the results presented in this study and on previously published data ([@pcv146-B22]), we propose a schematic model ([Fig. 10](#pcv146-F10){ref-type="fig"}) to describe the effect of ABI1 regulation on MKKK18. Further analysis will help to elucidate novel regulatory mechanisms involving MKKK18. Fig. 10Regulation of MKKK18 activity and stability by ABI1 PP2C. Under standard conditions, active ABI1 protein phosphatase inhibits MKKK18 kinase activity and protein stability. ABA receptors and dephosphorylated MKKK18 are directed for degradation via the proteasome pathway. In the presence of ABA, ABI1 PP2C activity is restrained by binding of ABI1 to the ABA--PYL complex (ABA signaling is turned on). Active MKKK18 activates the downstream cascade. ABA inhibits the degradation of ABA receptors by limiting their polyubiquitination.

Materials and Methods
=====================

Plant growth and treatment
--------------------------

*Arabidopsis thaliana* Col-0 seeds were surface sterilized by treatment with 70% ethanol for 10 min, followed by four washes with sterile distilled water. The seeds were germinated on half-strength MS medium including 1% sucrose. After a 3 d stratification at 4°C, the seeds were transferred to a growth chamber and grown as described in [@pcv146-B35]. Seeds of *mkkk18-1* and *mkkk18-2* were obtained from the Nottingham Arabidopsis Stock Centre. The T-DNA insertion line for *abi1td* was described previously ([@pcv146-B35]).

Plasmid construction
--------------------

For protein interaction analysis in yeasts, full-length ABI1 BD constructs and the PP2C catalytic domain (ΔN-ABI1) were used as described in [@pcv146-B35] and [@pcv146-B37], respectively. MKKK18 AD constructs were PCR-amplified using specific primer pairs (MKKK18fEcoRI and MKKK18rSacI), cloned into the pGEM-T Easy vector (Promega), excised as *Eco*RI--*Sac*I restriction fragments, and ligated into the pACT2-AD vector. To generate the MKKK18 BD construct, a pUNI clone for MKKK18 (U18652) was recombined with the pACT2 vector using Cre recombinase ([@pcv146-B32]). To generate the pENTR™/SD/D-TOPO® vector for facilitating the generation of C- or N-terminal in-frame MKKK18 fusions, cDNA for MKKK18 was amplified using *Pfu* polymerase, cloned into pENTR and then sequenced. To generate the recombinant GST- or His-tagged vectors, the pENTR-MKKK18 constructs were recombined with the Gateway® pDEST™15, Gateway® pDEST™17 or Gateway® pDEST™24 vectors using Gateway® LR Clonase® II Enzyme Mix (Invitrogen). For the BiFC assay, cDNAs for ABI1, ABI2 and MKKK18 were amplified using *Pfu* polymerase and then cloned into the pENTR/SD/D-TOPO vector (Invitrogen) (see [Supplementary Methods S1](http://pcp.oxfordjournals.org/lookup/suppl/doi:10.1093/pcp/pcv146/-/DC1) for details on the construction of the BiFC vector). The clones generated were digested with *Mlu*I, and the cDNA-containing restriction fragments were recombined with the pSAT3-cCFP-DEST and the pSAT5-DEST-nVenus vectors using Gateway® LR Clonase® II Enzyme Mix (Invitrogen), resulting in ncECFP--ABI1/2 and cnVenus--MKKK18 constructs, respectively. The DNA construct for MKKK18 localization and plant transformation (*35S:MKKK18-GFP*) was prepared in pEarleyGate 103 ([@pcv146-B14]) using Gateway technology. Two out of six independent Col-0/*35S:MKKK18-GFP* transgenic lines were tested: \#1 and \#2. Site-directed mutagenesis of *MKKK18* was performed using a QuikChange II XL Site-Directed Mutagenesis Kit (Agilent) according to the manufacturer's protocol, and using the following oligonucleotides: K32M *For* 5′-CACTCGCCGTAATGTCCGCCGAGT-3′ and *Rev* 5′-ACTCGGCGGACATTACGGCGAGTG-3′; and T161E *For* 5′-GGTTGAACCGGAAATAGAGGAACCGGTTAGAGGAAC*-*3′ and *Rev* 5′-GTTCCTCTAACCGGTTCCTCTATTTCCGGTTCAACC*-*3′.

Construction of the *MKKK18* promoter--GUS vector
-------------------------------------------------

The 1,622 bp *MKKK18* promoter region was generated from genomic Arabidopsis DNA by PCR amplification using the primers indicated in [Supplementary Table S1](http://pcp.oxfordjournals.org/lookup/suppl/doi:10.1093/pcp/pcv146/-/DC1). The promoter sequence was verified by sequencing. BLAST analysis confirmed that isolated fragments had 99% identity with the known *MKKK18* promoter region deposited in the TAIR database. To produce the 1,622 bp *MKKK18* promoter region (the *D::GUS* construct), the PCR products were cloned into the pGEM T-Easy vector system (Promega), sequenced and cloned into the *Kpn*I--*Pst*I sites of the pBI101 vector. The promoter--reporter fusion construct was transformed into *Agrobacterium tumefaciens* strain LBA4404 and used for *A. thaliana* (Col-0) plant transformations using the floral dip method ([@pcv146-B6]). More than five independent transgenic lines were produced and tested for responsiveness by GUS histochemical assays. Three representative lines were selected for detailed characterization and showed the same expression pattern under all conditions tested.

Histochemical localization of *GUS* expression
----------------------------------------------

For histochemical analysis of *GUS* expression, T~2~ seeds of Col-0/*ProMKKK18*:*GUS* were grown as described and exposed to 1 µM ABA for 24 h. Tissue samples were immersed in staining buffer \[100 mM sodium phosphate, pH 7.0, 10 mM EDTA, 0.5 mM K~4~Fe(CN)~6~, 0.5 mM K~3~Fe(CN)~6~, 0.1% Triton X-100 and 1 mM X-gluc\], and incubated overnight at 37°C. After the GUS reaction, plant samples were incubated in 80% ethanol to remove chlorophyll from the green tissues. GUS staining patterns were recorded using a Zeiss Stereo Lumar V12 microscope.

Analyses of the *mkkk18-1* and *mkkk18-2* T-DNA insertion lines
---------------------------------------------------------------

The *mkkk18-1* and the *mkkk18-2* T-DNA insertion lines were isolated from SALK insertion lines (SALK_087047) and from the GABI-Kat collection (GK-244G02), respectively. The qPCR analyses were performed as described in [@pcv146-B35].

Stomatal index and stomatal aperture
------------------------------------

The SI was calculated based on the method described in [@pcv146-B65]). Counts of stomata and pavement cells were performed on five areas of each cotyledon from 10 separate seedlings, giving 100 measurements per experiment, using a Nikon Eclipse Ti microscope with a Nikon Digital Sight DS-Fi1c camera. The SI was calculated individually for each cotyledon using the formula: SI = \[number of stomata/(number of other epidermal cells + number of stomata)\]. For statistical analysis, Student's *t*-test was performed. For guard cell aperture measurements, rosette leaves of 5-week-old plants were floated in opening buffer (10 mM KCl, 7.5 mM EGTA, 10 mM MES-KOH, at pH 6.15) and incubated at 20°C under light conditions for 2 h to open the stomata. Subsequently, the same opening buffer was supplemented with either 15 µM ABA, 1 mM H~2~O~2~ or 1 mM CaCl~2~, and the leaves were incubated for another 2 h. The stomatal apertures (width divided by length) along three different epidermal transects were measured using a Nikon Eclipse Ti (with Nikon Digital Sight DS-Fi1c digital camera) and Nikon NIS Elements AR software. No less than 60 mature stomata were analyzed per transect.

Protoplast isolation, transformation and transient expression assays
--------------------------------------------------------------------

Transient expression assays were performed using protoplasts from Arabidopsis mesophyll cells. Protoplast isolation, transformation and transient expression assays were performed based on methods described in [@pcv146-B37]. Protoplasts were transiently transformed with 5 µg of plasmid, collected by centrifugation and resuspended in lysis buffer for further analysis. Transient protein expression in tobacco leaves was performed as described in [@pcv146-B68]. *Agrobacterium tumefaciens* C58C1 cells with different MKKK18 constructs were mixed with an equal volume of *Agrobacterium* C58C1 (*pCH32 35S:p19*) expressing the silencing suppressor p19. The bacteria were injected into fully expanded leaves of tobacco plants, and were examined after 5 days.

Kinase activity assays
----------------------

For the in vitro kinase assays, the MKKK18 immunocomplex assay was performed based on methods described in [@pcv146-B37]. Briefly, tissue extracts containing 500 µg of total protein were immunoprecipitated for 1 h at 4°C with 5 µg of anti-GFP or anti-MKKK18 antibody pre-coupled to Dynabeads Protein-A (Invitrogen). This mixture was washed three times with wash buffer I (20 mM Tris--HCl, 5 mM EDTA, 100 mM NaCl, 1% Triton X-100), once with the same buffer but containing 1 M NaCl, and once with kinase buffer \[20 mM HEPES, pH 7.5, 10 mM MgCl~2~, 1 mM dithiothreitol (DTT)\]. A half-aliquot of MKKK18 was used to phosphorylate 5 µg of substrate (MBP; Sigma) in kinase buffer containing 25 µM ATP and \[γ-^32^P\]ATP (2 µCi per reaction) at 30°C. Another half-aliquot of activated MKKK18 was assayed under the same conditions without radioactive ATP. The reactions were stopped by the addition of SDS-loading buffer after 60 min. SDS--PAGE reaction products were analyzed using autoradiography or Western blotting.

Immunoblotting
--------------

Proteins were separated by 10% SDS--PAGE (BioRad) and were transferred onto Immobilon-P membranes (Millipore). The membranes were blocked for 1 h in PBS-T containing a 3% blocking solution, washed three times and incubated for 1 h with rabbit anti-GFP (1 : 200; sc-8334, Santa Cruz Biotechnology), StrepMAB-Classic (1 : 3,000; IBA BioTAGnology), anti-GST-Tag (1 : 5,000; Sigma), anti-MKKK18 antibody (AS13 2673, Agrisera), anti-ABI1 (AS12 1861, Agrisera) and anti-ABI2 (AS12 1871, Agrisera). After washing three times, the membranes were incubated for 1 h with the appropriate secondary antibody. Detection was performed with ECL (Thermo Scientific) according to the manufacturer's instructions.

GST-tagged protein overexpression, purification, pull-down and cell-free degradation assays
-------------------------------------------------------------------------------------------

*Escherichia coli* BL21(DE3) competent cells were transformed with recombinant MKKK18--GST, GST--ABI1 and GST--ABI2 expression constructs. Bacterial growth, isolation of recombinant GST fusion proteins, pull-down assays and cell-free degradation assays were conducted according to [@pcv146-B37]. The abundance of MKKK18--GST was determined using anti-GST antibodies.

Bimolecular fluorescence complementation (BIFC) in Arabidopsis protoplasts
--------------------------------------------------------------------------

For the BiFC analysis, various combinations of plasmids encoding cECFP, nVenus fusion proteins and red fluorescent proteins (RFPs) as an internal control were mixed at a 1 : 1 : 1 (w/w) ratio, and the mixture of plasmid DNA was used for polyethylene glycol-mediated transformation as described by [@pcv146-B37].

Supplementary data
==================

[Supplementary data](http://pcp.oxfordjournals.org/lookup/suppl/doi:10.1093/pcp/pcv146/-/DC1) are available at PCP online.
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